Bluebird Bio secures up to $175M in debt financing with Hercules Capital to extend its cash runway beyond the next 24 months.
RECENTLY ACQUIREDMar 18, 2024
Amount Raised
$175 Million
Round Type
Debt Financing
SomervilleBiotechnologyHealth CareTherapeutics
Investors
Hercules Capital
Description
Bluebird Bio has secured up to $175 million in debt financing with Hercules Capital in a five-year term loan facility, which provides for the funds in separate tranches. The firm anticipates that the funding will extend its cash runway beyond the next 24 months.
Who to call at bluebird bio, and when
A new round usually means bluebird bio is about to hire and buy. The teams that reach out first get the meeting.
An alert the day bluebird bio raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at bluebird bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at bluebird bio. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
bluebird bio
Location
455 Grand Union Boulevard
Somerville, Massachusetts, United States
About
bluebird bio is a commercial-stage biotherapeutics company focused on developing and delivering gene therapies for severe genetic diseases. With more than a decade of scientific leadership in gene therapy and three FDA-approved therapies for sickle cell disease, β-thalassemia, and cerebral adrenoleukodystrophy, the company is committed to ensuring access, reliability, and patient-centered care.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment bluebird bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
SomervilleBiotechnologyHealth CareTherapeutics